CY1107268T1 - Μν γονιδιο και πρωτεϊνη - Google Patents
Μν γονιδιο και πρωτεϊνηInfo
- Publication number
- CY1107268T1 CY1107268T1 CY20081100058T CY081100058T CY1107268T1 CY 1107268 T1 CY1107268 T1 CY 1107268T1 CY 20081100058 T CY20081100058 T CY 20081100058T CY 081100058 T CY081100058 T CY 081100058T CY 1107268 T1 CY1107268 T1 CY 1107268T1
- Authority
- CY
- Cyprus
- Prior art keywords
- protein
- proteins
- polypeptides
- disclosed
- encode
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 11
- 102000004169 proteins and genes Human genes 0.000 title abstract 8
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 239000013598 vector Substances 0.000 abstract 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000017455 cell-cell adhesion Effects 0.000 abstract 1
- 239000003145 cytotoxic factor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000001855 preneoplastic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/178,115 US6297041B1 (en) | 1992-03-11 | 1998-10-23 | MN gene and protein |
| US09/177,776 US6297051B1 (en) | 1997-01-24 | 1998-10-23 | MN gene and protein |
| EP99955151A EP1123387B1 (en) | 1998-10-23 | 1999-10-22 | Mn gene and protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107268T1 true CY1107268T1 (el) | 2012-11-21 |
Family
ID=26873634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100058T CY1107268T1 (el) | 1998-10-23 | 2008-01-16 | Μν γονιδιο και πρωτεϊνη |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1123387B1 (enExample) |
| JP (3) | JP3910798B2 (enExample) |
| AT (1) | ATE376056T1 (enExample) |
| AU (1) | AU758957C (enExample) |
| CA (1) | CA2347649C (enExample) |
| CY (1) | CY1107268T1 (enExample) |
| DE (1) | DE69937364T2 (enExample) |
| DK (1) | DK1123387T3 (enExample) |
| ES (1) | ES2296412T3 (enExample) |
| NO (1) | NO328884B1 (enExample) |
| WO (1) | WO2000024913A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6902890B1 (en) | 1999-11-04 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing monitoring, staging, imaging and treating cancer |
| US20040077081A1 (en) | 2001-02-07 | 2004-04-22 | Egbert Oosterwijk | Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| AR036833A1 (es) * | 2001-10-18 | 2004-10-06 | Bayer Corp | Anticuerpos humanos que se unen a mn y tienen actividad neutralizante de la adhesion celular. |
| US7910549B2 (en) * | 2001-12-13 | 2011-03-22 | Institute Of Virology Of The Slovak Academy Of Sciences | MN gene and protein |
| CA2477163C (en) | 2002-02-21 | 2010-07-27 | Institute Of Virology | Soluble form of carbonic anhydrase ix (s-ca-ix), assays to detect s-ca ix, and ca ix's coexpression with her-2/neu/c-erbb-2, and ca ix-specific monoclonal antibodies to non-immunodominant epitopes |
| SI2508596T1 (sl) | 2002-02-21 | 2016-01-29 | Institute Of Virology Slovak Academy Of Sciences | Monoklonska protitelesa, specifična za MN/CA IX, proizvedena iz MN/CA IX deficientnih miši, in postopki uporabe |
| AU2003223186A1 (en) * | 2002-05-23 | 2004-01-23 | Bayer Healthcare | SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 |
| EP1524995B1 (en) | 2002-07-01 | 2011-12-21 | Wilex AG | Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| AU2003268180A1 (en) * | 2002-08-23 | 2004-03-11 | Chiron Corporation | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| US7550424B2 (en) | 2002-11-26 | 2009-06-23 | Institute Of Virology Slovak Academy Of Sciences | CA IX-specific inhibitors |
| US7524634B2 (en) * | 2003-10-16 | 2009-04-28 | Institute Of Virology, Slovak Academy Of Sciences | MN/CA IX and cancer prognosis |
| AU2005241093B2 (en) | 2004-05-04 | 2008-06-05 | Institute Of Virology Of Slovak Academy Of Sciences | MN/CA IX/ CA9 and renal cancer prognosis |
| US7820159B2 (en) | 2006-10-31 | 2010-10-26 | Instiute of Virology of the Slovak Academy of Sciences | MN/CA IX and EGFR pathway inhibition |
| US8399624B1 (en) * | 2009-06-25 | 2013-03-19 | Esbatech, An Alcon Biomedical Research Unit Llc | Acceptor framework for CDR grafting |
| ES2703572T3 (es) | 2013-02-22 | 2019-03-11 | Heidelberg Pharma Ag | Tratamiento del cáncer basado en la estratificación de CAIX |
| CZ2014527A3 (cs) * | 2014-08-05 | 2016-02-17 | Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. | Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2192678C (en) * | 1994-06-15 | 2010-12-14 | Jan Zavada | Mn gene and protein |
| US6329501B1 (en) * | 1997-05-29 | 2001-12-11 | Auburn University | Methods and compositions for targeting compounds to muscle |
| AU3714499A (en) * | 1998-05-14 | 1999-11-29 | Pasteur Merieux Serums Et Vaccins | Hepatitis c virus mimotopes |
-
1999
- 1999-10-22 EP EP99955151A patent/EP1123387B1/en not_active Expired - Lifetime
- 1999-10-22 DE DE69937364T patent/DE69937364T2/de not_active Expired - Lifetime
- 1999-10-22 AU AU11323/00A patent/AU758957C/en not_active Expired
- 1999-10-22 WO PCT/US1999/024879 patent/WO2000024913A2/en not_active Ceased
- 1999-10-22 JP JP2000578465A patent/JP3910798B2/ja not_active Expired - Fee Related
- 1999-10-22 EP EP06076937A patent/EP1832653A1/en not_active Withdrawn
- 1999-10-22 ES ES99955151T patent/ES2296412T3/es not_active Expired - Lifetime
- 1999-10-22 DK DK99955151T patent/DK1123387T3/da active
- 1999-10-22 CA CA2347649A patent/CA2347649C/en not_active Expired - Lifetime
- 1999-10-22 AT AT99955151T patent/ATE376056T1/de active
-
2001
- 2001-04-19 NO NO20011926A patent/NO328884B1/no not_active IP Right Cessation
-
2006
- 2006-11-27 JP JP2006318591A patent/JP4044597B2/ja not_active Expired - Lifetime
-
2007
- 2007-09-10 JP JP2007233872A patent/JP4488373B2/ja not_active Expired - Fee Related
-
2008
- 2008-01-16 CY CY20081100058T patent/CY1107268T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU758957B2 (en) | 2003-04-03 |
| DE69937364T2 (de) | 2008-07-17 |
| JP4488373B2 (ja) | 2010-06-23 |
| EP1832653A1 (en) | 2007-09-12 |
| WO2000024913A2 (en) | 2000-05-04 |
| CA2347649A1 (en) | 2000-05-04 |
| ATE376056T1 (de) | 2007-11-15 |
| WO2000024913A3 (en) | 2000-09-14 |
| CA2347649C (en) | 2012-03-13 |
| JP2002528085A (ja) | 2002-09-03 |
| AU1132300A (en) | 2000-05-15 |
| JP2008069151A (ja) | 2008-03-27 |
| NO20011926L (no) | 2001-06-19 |
| NO20011926D0 (no) | 2001-04-19 |
| AU758957C (en) | 2004-08-12 |
| EP1123387A2 (en) | 2001-08-16 |
| EP1123387B1 (en) | 2007-10-17 |
| JP3910798B2 (ja) | 2007-04-25 |
| DK1123387T3 (da) | 2008-02-25 |
| DE69937364D1 (de) | 2007-11-29 |
| JP2007145843A (ja) | 2007-06-14 |
| ES2296412T3 (es) | 2008-04-16 |
| NO328884B1 (no) | 2010-06-07 |
| JP4044597B2 (ja) | 2008-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107268T1 (el) | Μν γονιδιο και πρωτεϊνη | |
| NO20100685L (no) | Polypeptid samt anvendelse derav og peptidkompleks, og fremgangsmate for identifisering av et organisk eller uorganisk molekyl | |
| ATE365744T1 (de) | Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen | |
| DK368588A (da) | Bindingsmolekyler med en enkelt polypeptidkaede | |
| DK1294876T3 (da) | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse | |
| ATE537258T1 (de) | Il-17-homologe polypeptide und ihre therapeutische verwendung | |
| NO990086D0 (no) | Avkortete, oppl÷selige tumornekrosefaktorreseptorer av type I og type II | |
| NO20020861D0 (no) | PD-1, en reseptor for B7-4, og anvendelser derav | |
| AU2894289A (en) | Domain-modified constant region antibodies | |
| WO2002005843A3 (en) | Human rrp sequences and methods of use | |
| WO2002092758A8 (en) | Gastrokines and derived peptides including inhibitors | |
| DE60313743D1 (de) | Mit influenzavirus-hämagglutinin und influenza m2 pseudotypisierte retrovirusvektoren zur zuführung von genen | |
| CY1110308T1 (el) | Μοριο νουκλεϊνικου οξεος, το οποιο περιλαμβανει μια κωδικευσουσα για αιμοκυανινη ακολουθια νουκλεϊνικου οξεος και τουλαχιστον μια ακολουθια ιντρονιου | |
| DK0789763T3 (da) | ICAM-4-materialer og fremgangsmåder | |
| DE59309978D1 (de) | Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung | |
| ATE366810T1 (de) | Menschliche p51-gene und deren genprodukte | |
| SE0003573D0 (sv) | Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology | |
| EP1679372A4 (en) | NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF | |
| DK1300417T3 (da) | Secerneret og transmembrant polypeptid og nucleinsyre kodende derfor | |
| DK1241180T3 (da) | Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette | |
| DK1241184T3 (da) | Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette | |
| DK1249491T3 (da) | Nucleinsyre, der opformeres i humane tumorer samt beslægtede materialer og fremgangsmåder | |
| DK1241185T3 (da) | Nucleinsyrer, der er opformeret i humane tumorer, samt beslægtede materialer og fremgangsmåder |